nodes	percent_of_prediction	percent_of_DWPC	metapath
Dapagliflozin—SLC5A4—Orphan transporters—GABRA2—conduct disorder	0.0811	0.0811	CbGpPWpGaD
Dapagliflozin—SLC5A1—Orphan transporters—GABRA2—conduct disorder	0.0615	0.0615	CbGpPWpGaD
Dapagliflozin—SLC5A2—Orphan transporters—GABRA2—conduct disorder	0.0615	0.0615	CbGpPWpGaD
Dapagliflozin—SLC5A11—NRF2 pathway—SLC6A4—conduct disorder	0.0538	0.0538	CbGpPWpGaD
Dapagliflozin—UGT2B7—Estrogen metabolism—COMT—conduct disorder	0.0423	0.0423	CbGpPWpGaD
Dapagliflozin—SLC5A4—NRF2 pathway—SLC6A4—conduct disorder	0.0393	0.0393	CbGpPWpGaD
Dapagliflozin—UGT1A9—Estrogen metabolism—COMT—conduct disorder	0.0344	0.0344	CbGpPWpGaD
Dapagliflozin—SLC5A1—NRF2 pathway—SLC6A4—conduct disorder	0.0298	0.0298	CbGpPWpGaD
Dapagliflozin—SLC5A2—NRF2 pathway—SLC6A4—conduct disorder	0.0298	0.0298	CbGpPWpGaD
Dapagliflozin—SLC5A11—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.0272	0.0272	CbGpPWpGaD
Dapagliflozin—UGT2B4—Phase II conjugation—COMT—conduct disorder	0.0261	0.0261	CbGpPWpGaD
Dapagliflozin—CYP1A2—Methylation—COMT—conduct disorder	0.0202	0.0202	CbGpPWpGaD
Dapagliflozin—SLC5A4—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.0198	0.0198	CbGpPWpGaD
Dapagliflozin—CYP1A1—Estrogen metabolism—COMT—conduct disorder	0.0198	0.0198	CbGpPWpGaD
Dapagliflozin—UGT2B4—Biological oxidations—COMT—conduct disorder	0.0153	0.0153	CbGpPWpGaD
Dapagliflozin—UGT2B4—Biological oxidations—MAOA—conduct disorder	0.0152	0.0152	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metapathway biotransformation—COMT—conduct disorder	0.0151	0.0151	CbGpPWpGaD
Dapagliflozin—SLC5A1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.015	0.015	CbGpPWpGaD
Dapagliflozin—SLC5A2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.015	0.015	CbGpPWpGaD
Dapagliflozin—CYP1A1—Melatonin metabolism and effects—MAOA—conduct disorder	0.0134	0.0134	CbGpPWpGaD
Dapagliflozin—CYP1A1—Oxidative Stress—MAOA—conduct disorder	0.013	0.013	CbGpPWpGaD
Dapagliflozin—CYP1A2—Estrogen metabolism—COMT—conduct disorder	0.0126	0.0126	CbGpPWpGaD
Dapagliflozin—UGT2B7—Phase II conjugation—COMT—conduct disorder	0.0119	0.0119	CbGpPWpGaD
Dapagliflozin—UGT2B7—NRF2 pathway—SLC6A4—conduct disorder	0.0105	0.0105	CbGpPWpGaD
Dapagliflozin—CYP2D6—Melatonin metabolism and effects—MAOA—conduct disorder	0.0101	0.0101	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—CGA—conduct disorder	0.00989	0.00989	CbGpPWpGaD
Dapagliflozin—CYP3A4—Estrogen metabolism—COMT—conduct disorder	0.00972	0.00972	CbGpPWpGaD
Dapagliflozin—UGT1A9—Phase II conjugation—COMT—conduct disorder	0.00967	0.00967	CbGpPWpGaD
Dapagliflozin—CYP1A2—Melatonin metabolism and effects—MAOA—conduct disorder	0.00854	0.00854	CbGpPWpGaD
Dapagliflozin—UGT1A9—NRF2 pathway—SLC6A4—conduct disorder	0.00851	0.00851	CbGpPWpGaD
Dapagliflozin—CYP2A6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00815	0.00815	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—CGA—conduct disorder	0.0075	0.0075	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—CGA—conduct disorder	0.0075	0.0075	CbGpPWpGaD
Dapagliflozin—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00697	0.00697	CbGpPWpGaD
Dapagliflozin—UGT2B7—Biological oxidations—COMT—conduct disorder	0.00696	0.00696	CbGpPWpGaD
Dapagliflozin—UGT2B7—Biological oxidations—MAOA—conduct disorder	0.00691	0.00691	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metapathway biotransformation—COMT—conduct disorder	0.00686	0.00686	CbGpPWpGaD
Dapagliflozin—CYP2A6—NRF2 pathway—SLC6A4—conduct disorder	0.00656	0.00656	CbGpPWpGaD
Dapagliflozin—CYP1A1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00607	0.00607	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—CGA—conduct disorder	0.00579	0.00579	CbGpPWpGaD
Dapagliflozin—UGT1A9—Biological oxidations—COMT—conduct disorder	0.00566	0.00566	CbGpPWpGaD
Dapagliflozin—UGT1A9—Biological oxidations—MAOA—conduct disorder	0.00562	0.00562	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metapathway biotransformation—COMT—conduct disorder	0.00558	0.00558	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00481	0.00481	CbGpPWpGaD
Dapagliflozin—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00457	0.00457	CbGpPWpGaD
Dapagliflozin—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00453	0.00453	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—COMT—conduct disorder	0.00447	0.00447	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—MAOA—conduct disorder	0.00443	0.00443	CbGpPWpGaD
Dapagliflozin—CYP2A6—Biological oxidations—COMT—conduct disorder	0.00436	0.00436	CbGpPWpGaD
Dapagliflozin—CYP2A6—Biological oxidations—MAOA—conduct disorder	0.00433	0.00433	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.004	0.004	CbGpPWpGaD
Dapagliflozin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.004	0.004	CbGpPWpGaD
Dapagliflozin—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00387	0.00387	CbGpPWpGaD
Dapagliflozin—CYP1A2—Phase II conjugation—COMT—conduct disorder	0.00354	0.00354	CbGpPWpGaD
Dapagliflozin—UGT1A9—PPARA activates gene expression—EP300—conduct disorder	0.00347	0.00347	CbGpPWpGaD
Dapagliflozin—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—conduct disorder	0.00339	0.00339	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—COMT—conduct disorder	0.00338	0.00338	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—COMT—conduct disorder	0.00338	0.00338	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—MAOA—conduct disorder	0.00336	0.00336	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—MAOA—conduct disorder	0.00336	0.00336	CbGpPWpGaD
Dapagliflozin—CYP1A1—Biological oxidations—COMT—conduct disorder	0.00325	0.00325	CbGpPWpGaD
Dapagliflozin—CYP1A1—Biological oxidations—MAOA—conduct disorder	0.00323	0.00323	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metapathway biotransformation—COMT—conduct disorder	0.0032	0.0032	CbGpPWpGaD
Dapagliflozin—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00299	0.00299	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00276	0.00276	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—CGA—conduct disorder	0.00264	0.00264	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—COMT—conduct disorder	0.00261	0.00261	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—MAOA—conduct disorder	0.00259	0.00259	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00255	0.00255	CbGpPWpGaD
Dapagliflozin—CYP1A2—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.00255	0.00255	CbGpPWpGaD
Dapagliflozin—CYP2D6—Biological oxidations—COMT—conduct disorder	0.00244	0.00244	CbGpPWpGaD
Dapagliflozin—CYP2D6—Biological oxidations—MAOA—conduct disorder	0.00243	0.00243	CbGpPWpGaD
Dapagliflozin—CYP2C9—Biological oxidations—COMT—conduct disorder	0.00242	0.00242	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	0.00241	0.00241	CbGpPWpGaD
Dapagliflozin—CYP2C9—Biological oxidations—MAOA—conduct disorder	0.00241	0.00241	CbGpPWpGaD
Dapagliflozin—ABCB1—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.00239	0.00239	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metapathway biotransformation—COMT—conduct disorder	0.00239	0.00239	CbGpPWpGaD
Dapagliflozin—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—conduct disorder	0.00234	0.00234	CbGpPWpGaD
Dapagliflozin—SLC5A4—Disease—EP300—conduct disorder	0.00229	0.00229	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—CGA—conduct disorder	0.00214	0.00214	CbGpPWpGaD
Dapagliflozin—CYP1A2—Biological oxidations—COMT—conduct disorder	0.00207	0.00207	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00206	0.00206	CbGpPWpGaD
Dapagliflozin—CYP1A2—Biological oxidations—MAOA—conduct disorder	0.00206	0.00206	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metapathway biotransformation—COMT—conduct disorder	0.00204	0.00204	CbGpPWpGaD
Dapagliflozin—CYP1A1—PPARA activates gene expression—EP300—conduct disorder	0.00199	0.00199	CbGpPWpGaD
Dapagliflozin—ABCB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00197	0.00197	CbGpPWpGaD
Dapagliflozin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—conduct disorder	0.00195	0.00195	CbGpPWpGaD
Dapagliflozin—SLC5A4—Metabolism—EP300—conduct disorder	0.00192	0.00192	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00176	0.00176	CbGpPWpGaD
Dapagliflozin—SLC5A1—Disease—EP300—conduct disorder	0.00173	0.00173	CbGpPWpGaD
Dapagliflozin—SLC5A2—Disease—EP300—conduct disorder	0.00173	0.00173	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—CGA—conduct disorder	0.00165	0.00165	CbGpPWpGaD
Dapagliflozin—CYP3A4—Biological oxidations—COMT—conduct disorder	0.0016	0.0016	CbGpPWpGaD
Dapagliflozin—CYP3A4—Biological oxidations—MAOA—conduct disorder	0.00159	0.00159	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	0.00158	0.00158	CbGpPWpGaD
Dapagliflozin—SLC5A1—Metabolism—EP300—conduct disorder	0.00145	0.00145	CbGpPWpGaD
Dapagliflozin—SLC5A2—Metabolism—EP300—conduct disorder	0.00145	0.00145	CbGpPWpGaD
Dapagliflozin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—conduct disorder	0.00134	0.00134	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—CGA—conduct disorder	0.00123	0.00123	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—COMT—conduct disorder	0.00119	0.00119	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—MAOA—conduct disorder	0.00118	0.00118	CbGpPWpGaD
Dapagliflozin—UGT2B4—Metabolism—EP300—conduct disorder	0.00112	0.00112	CbGpPWpGaD
Dapagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.00102	0.00102	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—CGA—conduct disorder	0.000983	0.000983	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—COMT—conduct disorder	0.000967	0.000967	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—MAOA—conduct disorder	0.00096	0.00096	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000931	0.000931	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—CGA—conduct disorder	0.000926	0.000926	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—CGA—conduct disorder	0.000918	0.000918	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—CGA—conduct disorder	0.000785	0.000785	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—COMT—conduct disorder	0.000746	0.000746	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—MAOA—conduct disorder	0.00074	0.00074	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—CGA—conduct disorder	0.000606	0.000606	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—COMT—conduct disorder	0.000555	0.000555	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—MAOA—conduct disorder	0.000552	0.000552	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000535	0.000535	CbGpPWpGaD
Dapagliflozin—UGT2B7—Metabolism—EP300—conduct disorder	0.00051	0.00051	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—COMT—conduct disorder	0.000444	0.000444	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—MAOA—conduct disorder	0.000441	0.000441	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—COMT—conduct disorder	0.000418	0.000418	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—MAOA—conduct disorder	0.000415	0.000415	CbGpPWpGaD
Dapagliflozin—UGT1A9—Metabolism—EP300—conduct disorder	0.000415	0.000415	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—COMT—conduct disorder	0.000414	0.000414	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—MAOA—conduct disorder	0.000412	0.000412	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000399	0.000399	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—COMT—conduct disorder	0.000354	0.000354	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—MAOA—conduct disorder	0.000352	0.000352	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000341	0.000341	CbGpPWpGaD
Dapagliflozin—CYP2A6—Metabolism—EP300—conduct disorder	0.00032	0.00032	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—COMT—conduct disorder	0.000273	0.000273	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—MAOA—conduct disorder	0.000271	0.000271	CbGpPWpGaD
Dapagliflozin—CYP1A1—Metabolism—EP300—conduct disorder	0.000238	0.000238	CbGpPWpGaD
Dapagliflozin—ABCB1—Metabolism—EP300—conduct disorder	0.00019	0.00019	CbGpPWpGaD
Dapagliflozin—CYP2D6—Metabolism—EP300—conduct disorder	0.000179	0.000179	CbGpPWpGaD
Dapagliflozin—CYP2C9—Metabolism—EP300—conduct disorder	0.000178	0.000178	CbGpPWpGaD
Dapagliflozin—CYP1A2—Metabolism—EP300—conduct disorder	0.000152	0.000152	CbGpPWpGaD
Dapagliflozin—CYP3A4—Metabolism—EP300—conduct disorder	0.000117	0.000117	CbGpPWpGaD
